Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.0506
-0.0035 (-6.47%)
At close: Nov 15, 2024, 4:00 PM
0.0484
-0.0022 (-4.35%)
After-hours: Nov 15, 2024, 7:52 PM EST
Psyence Biomedical Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Net Income | -51.16 | -51.16 | -3.21 | -2.32 |
| Depreciation & Amortization | 0 | 0 | - | - |
| Stock-Based Compensation | 0.32 | 0.32 | 0.22 | 0.41 |
| Other Operating Activities | 49.07 | 49.07 | -0.08 | - |
| Change in Accounts Receivable | 0.11 | 0.11 | -0.11 | 0.12 |
| Change in Accounts Payable | -1.04 | -1.04 | 1.66 | 0.04 |
| Change in Other Net Operating Assets | -0.25 | -0.25 | -0.07 | 0 |
| Operating Cash Flow | -2.95 | -2.95 | -1.59 | -1.74 |
| Capital Expenditures | -0.01 | -0.01 | - | - |
| Other Investing Activities | - | - | - | -0.04 |
| Investing Cash Flow | -0.01 | -0.01 | - | -0.04 |
| Short-Term Debt Issued | 2.5 | 2.5 | - | - |
| Total Debt Issued | 2.5 | 2.5 | - | - |
| Short-Term Debt Repaid | -0.15 | -0.15 | - | - |
| Total Debt Repaid | -0.15 | -0.15 | - | - |
| Net Debt Issued (Repaid) | 2.35 | 2.35 | - | - |
| Other Financing Activities | - | - | 1.17 | -2.03 |
| Financing Cash Flow | 2.35 | 2.35 | 1.17 | -2.03 |
| Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - |
| Net Cash Flow | -0.6 | -0.6 | -0.42 | -3.82 |
| Free Cash Flow | -2.95 | -2.95 | -1.59 | -1.74 |
| Free Cash Flow Per Share | -0.45 | -0.45 | -0.32 | - |
| Levered Free Cash Flow | -1.71 | -1.71 | -0.32 | - |
| Unlevered Free Cash Flow | -1.68 | -1.68 | -0.32 | - |
| Change in Net Working Capital | 0.27 | 0.27 | -1.48 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.